🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

HoLEP vs BipolEP in Management of BPH Patients With Large Prostates

RecruitingNAAges 50 Years - anyMaleAssiut University
NCT06759194 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a non-inferiority prospective randomized comparative clinical trial aiming to prove the non-inferiority of bipolar enucleation of the prostate in comparison to holmium laser enucleation of the prostate in management of benign prostatic hyperplasia patients with large prostates and in turn its feasibility as an alternative procedure in hospitals with limited resources

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age \>50 years * Prostate volume \>80 ml * Failure of or noncompliance with medical treatment * IPSS \>15 * Qmax \<15 ml/sec * Urinary retention and fixed catheters with poor results on trial of voiding without catheter Exclusion Criteria: * Patients with active UTI * Prostate cancer * Bladder carcinoma * Urethral stricture * Neurogenic bladder disorders * Redo cases
💊

What it tests

  • Holmium Laser Enucleation of the Prostate
  • Bipolar Enucleation of the Prostate
📍

Where

1 site
Assiut University Urology Hospital
Asyut, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy